Adhd

Longer cumulative use of medication to treat attention-deficit/hyperactivity disorder (ADHD) is associated with a small, but statistically significant, increased risk for cardiovascular disease (CVD), results of a large Swedish nested case-control study suggest.

The increased risk was evident only for hypertension and arterial disease, was dose-dependent, and was higher for stimulant like methylphenidate than nonstimulant ADHD medications like atomoxetine. Link to full article here

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

Add Note

You do not have permission to view this form.

Sign In

Register

Reset Password

Please enter your username or email address, you will receive a link to create a new password via email.

Membership

An active membership is required for this action, please click on the button below to view the available plans.